2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide

C15H26N4O2 — CID 60940035

IUPAC2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide
SMILESC=CCNC(=O)CN1CCN(C(=O)C2CCCCN2)CC1
InChIInChI=1S/C15H26N4O2/c1-2-6-17-14(20)12-18-8-10-19(11-9-18)15(21)13-5-3-4-7-16-13/h2,13,16H,1,3-12H2,(H,17,20)
InChIKeyHHCCGKCINFEXQX-UHFFFAOYSA-N
MW294.40 g/mol
LogP-0.43
Rot. Bonds5

About 2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide

2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide (PubChem CID 60940035) has the molecular formula C15H26N4O2 and a molecular weight of 294.40 g/mol. Its IUPAC name is 2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide.

Molecular Properties

Compound Name2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide
PubChem CID60940035
Molecular FormulaC15H26N4O2
Molecular Weight294.40 g/mol
Exact Mass294.21
IUPAC Name2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide
SMILESC=CCNC(=O)CN1CCN(C(=O)C2CCCCN2)CC1
InChIInChI=1S/C15H26N4O2/c1-2-6-17-14(20)12-18-8-10-19(11-9-18)15(21)13-5-3-4-7-16-13/h2,13,16H,1,3-12H2,(H,17,20)
InChIKeyHHCCGKCINFEXQX-UHFFFAOYSA-N
XLogP-0.43
TPSA64.68 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500294.40
LogP ≤ 5-0.43
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[4-[(2R)-piperidine-2-carbonyl]piperazin-1-yl]-N-prop-2-enylacetamide;dihydrochloride
CID 119837819
N-methyl-2-[4-(pyrrolidine-2-carbonyl)piperazin-1-yl]acetamide
CID 60717609
2-[4-(oxolane-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide
CID 78787885
N-(2-methoxyethyl)-2-[4-(pyrrolidine-2-carbonyl)piperazin-1-yl]acetamide;dihydrochloride
CID 119836395
methyl 2-[4-[(2R)-pyrrolidine-2-carbonyl]piperazin-1-yl]acetate
CID 93376360
[(2R)-piperidin-2-yl]-(4-prop-2-ynylpiperazin-1-yl)methanone
CID 93375251
[4-(2-hydroxyethyl)piperazin-1-yl]-piperidin-2-ylmethanone
CID 43501381
N-(3-methylcyclohexyl)-2-[4-[(2R)-piperidine-2-carbonyl]piperazin-1-yl]acetamide;dihydrochloride
CID 119876760
azepan-2-yl-(4-prop-2-ynylpiperazin-1-yl)methanone
CID 64562668
2-[4-[(1R)-cyclohex-2-en-1-yl]piperazin-1-yl]-N-prop-2-enylacetamide
CID 95149850
piperidin-2-yl-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]methanone
CID 61259978
ethyl 4-(azepane-2-carbonyl)piperazine-1-carboxylate
CID 64563459

Frequently Asked Questions

What is the IUPAC name of 2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide?
The IUPAC name of 2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide (CID 60940035) is 2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide.
What is the SMILES notation for 2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide?
The canonical SMILES for 2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide is C=CCNC(=O)CN1CCN(C(=O)C2CCCCN2)CC1.
What is the InChIKey of 2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide?
The InChIKey is HHCCGKCINFEXQX-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H26N4O2/c1-2-6-17-14(20)12-18-8-10-19(11-9-18)15(21)13-5-3-4-7-16-13/h2,13,16H,1,3-12H2,(H,17,20).
What are the key properties of 2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide?
2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide has a molecular weight of 294.40 g/mol, XLogP of -0.43, 5 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(piperidine-2-carbonyl)piperazin-1-yl]-N-prop-2-enylacetamide is sourced from PubChem (CID 60940035), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).